Embecta Corp. (EMBC) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1209 ORANGE STREET WILMINGTON, DE 19801 |
| State of Incorp. | DE |
| Fiscal Year End | September 30 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 MRQ | 9/30/2024 | 9/30/2023 | 9/30/2022 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 210 | 268 | 327 | 331 | |||
| Cash and cash equivalent | 210 | 268 | 327 | 331 | |||
| Restricted cash and investments | 7 | 7 | |||||
| Receivables | 221 | 247 | 159 | 133 | |||
| Inventory, net of allowances, customer advances and progress billings | 169 | 172 | 152 | 123 | |||
| Inventory | 169 | 172 | 152 | 123 | |||
| Other current assets | 61 | 69 | 111 | 78 | |||
| Total current assets: | 667 | 761 | 749 | 665 | |||
| Noncurrent Assets | |||||||
| Finance lease, right-of-use asset, after accumulated amortization | 30 | 31 | 33 | 36 | |||
| Operating lease, right-of-use asset | 19 | 23 | 23 | 6 | |||
| Intangible assets, net (including goodwill) | 23 | 24 | 25 | 25 | |||
| Goodwill | 16 | 16 | 16 | 16 | |||
| Intangible assets, net (excluding goodwill) | 8 | 8 | 9 | 9 | |||
| Other undisclosed noncurrent assets | 409 | 447 | 385 | 355 | |||
| Total noncurrent assets: | 482 | 524 | 465 | 422 | |||
| TOTAL ASSETS: | 1,150 | 1,285 | 1,214 | 1,086 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 243 | 268 | 245 | 288 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 27 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 49 | ||
| Accounts payable | 116 | 134 | 127 | 108 | |||
| Accrued liabilities | 127 | 134 | 118 | 104 | |||
| Debt | 13 | 13 | 13 | 13 | |||
| Other undisclosed current liabilities | 43 | 93 | 96 | ||||
| Total current liabilities: | 298 | 374 | 354 | 301 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 1,565 | 1,596 | 1,625 | 1,635 | |||
| Long-term debt, excluding current maturities | 1,535 | 1,565 | 1,594 | 1,598 | |||
| Finance lease, liability | 30 | 30 | 32 | 33 | |||
| Liabilities, other than long-term debt | 11 | 12 | 15 | ||||
| Operating lease, liability | 11 | 12 | 15 | 4 | |||
| Total noncurrent liabilities: | 1,575 | 1,607 | 1,641 | 1,639 | |||
| Total liabilities: | 1,874 | 1,981 | 1,994 | 1,940 | |||
| Equity | |||||||
| Equity, attributable to parent | (769) | (738) | (822) | (891) | |||
| Common stock | 1 | 1 | 1 | 1 | |||
| Additional paid in capital | 58 | 53 | 28 | 10 | |||
| Accumulated other comprehensive loss | (320) | (293) | (309) | (325) | |||
| Accumulated deficit | (508) | (499) | (541) | (577) | |||
| Total equity: | (769) | (738) | (822) | (891) | |||
| Other undisclosed liabilities and equity | 45 | 42 | 42 | 38 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,150 | 1,285 | 1,214 | 1,086 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 TTM | 9/30/2024 | 9/30/2023 | 9/30/2022 | ||
|---|---|---|---|---|---|---|
| Revenues | 1,108 | 1,123 | 1,121 | 1,130 | ||
| Cost of revenue (Cost of Product and Service Sold) | (401) | (388) | (371) | (355) | ||
| Gross profit: | 706 | 735 | 750 | 775 | ||
| Operating expenses | (556) | (568) | (528) | (465) | ||
| Operating income: | 150 | 167 | 222 | 310 | ||
| Nonoperating expense | (8) | (10) | (9) | (7) | ||
| Interest and debt expense | (2) | (2) | ||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (2) | |||||
| Income from continuing operations before equity method investments, income taxes: | 139 | 154 | 210 | 303 | ||
| Other undisclosed loss from continuing operations before income taxes | (110) | (110) | (105) | (46) | ||
| Income from continuing operations before income taxes: | 29 | 44 | 106 | 257 | ||
| Income tax expense (benefit) | 29 | 34 | (35) | (33) | ||
| Income from continuing operations: | 58 | 78 | 70 | 224 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 224 | |
| Net income available to common stockholders, diluted: | 58 | 78 | 70 | 224 | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 TTM | 9/30/2024 | 9/30/2023 | 9/30/2022 | ||
|---|---|---|---|---|---|---|
| Net income: | 58 | 78 | 70 | 224 | ||
| Comprehensive income: | 58 | 78 | 70 | 224 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (22) | 16 | 16 | (64) | ||
| Comprehensive income, net of tax, attributable to parent: | 36 | 95 | 86 | 159 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.